Form 8-K - Current report:
SEC Accession No. 0001493152-21-019582
Filing Date
2021-08-13
Accepted
2021-08-13 06:16:02
Documents
29
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41656
2 ex99-1.htm EX-99.1 32212
3 ex99-1_001.jpg GRAPHIC 3298
4 ex99-2.htm EX-99.2 12044
5 ex99-2_001.jpg GRAPHIC 142823
6 ex99-2_002.jpg GRAPHIC 485901
7 ex99-2_003.jpg GRAPHIC 354089
8 ex99-2_004.jpg GRAPHIC 546708
9 ex99-2_005.jpg GRAPHIC 440156
10 ex99-2_006.jpg GRAPHIC 499275
11 ex99-2_007.jpg GRAPHIC 401607
12 ex99-2_008.jpg GRAPHIC 276279
13 ex99-2_009.jpg GRAPHIC 504686
14 ex99-2_010.jpg GRAPHIC 437843
15 ex99-2_011.jpg GRAPHIC 466110
16 ex99-2_012.jpg GRAPHIC 504411
17 ex99-2_013.jpg GRAPHIC 379129
18 ex99-2_014.jpg GRAPHIC 309198
  Complete submission text file 0001493152-21-019582.txt   8188592

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE pcsa-20210812.xsd EX-101.SCH 3069
20 XBRL LABEL FILE pcsa-20210812_lab.xml EX-101.LAB 34915
21 XBRL PRESENTATION FILE pcsa-20210812_pre.xml EX-101.PRE 22818
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3782
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 211169623
SIC: 2834 Pharmaceutical Preparations